| Baulande S, Lasnier F, Lucas M, Pairault J. 2001. Adiponutrin, a transmembrane protein corresponding to a novel dietary-and obesity-linked mRNA specifically expressed in the adipose lineage. Journal of Biological Chemistry, 276, 33336–33344.Bedell V M, Wang Y, Campbell J M, Poshusta T L, Starker C G, Krug II R G, Tan W, Penheiter S G, Ma A C, Leung A Y. 2012. In vivo genome editing using a high-efficiency TALEN system. Nature, 491, 114–118.Brautbar A, Leary E, Rasmussen K, Wilson D P, Steiner R D, Virani S. 2015. Genetics of familial hypercholesterolemia. Current Atherosclerosis Reports, 17, 1–17.Brown A J, Fisher D A, Kouranova E, McCoy A, Forbes K, Wu Y, Henry R, Ji D, Chambers A, Warren J. 2013. Whole-rat conditional gene knockout via genome editing. Nature Methods, 10, 638–640.Choi J, Nannenga B, Demidov O N, Bulavin D V, Cooney A, Brayton C, Zhang Y, Mbawuike I N, Bradley A, Appella E. 2002. Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. Molecular and Cellular Biology, 22, 1094–1105.Cong L, Ran F A, Cox D, Lin S, Barretto R, Habib N, Hsu P D, Wu X, Jiang W, Marraffini L A. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science, 339, 819–823.Denis M, Marcinkiewicz J, Zaid A, Gauthier D, Poirier S, Lazure C, Seidah N G, Prat A. 2012. Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice. Circulation, 125, 894–901.Dupont N, Chauhan S, Arko-Mensah J, Castillo E F, Masedunskas A, Weigert R, Robenek H, Proikas-Cezanne T, Deretic V. 2014. Neutral lipid stores and lipase PNPLA5 contribute to autophagosome biogenesis. Current Biology, 24, 609–620.Fan L L, Lin M J, Chen Y Q, Huang H, Peng D Q, Xia K, Zhao S P, Xiang R. 2015. Novel mutations of low-density lipoprotein receptor gene in China patients with familial hypercholesterolemia. Applied Biochemistry and Biotechnology, 176, 101–109.Fu Y, Sander J D, Reyon D, Cascio V M, Joung J K. 2014. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nature Biotechnology, 32, 279–284.Gao J G, Simon M. 2007. A comparative study of human GS2, its paralogues, and its rat orthologue. Biochemical and Biophysical Research Communications, 360, 501–506.Gasiunas G, Barrangou R, Horvath P, Siksnys V. 2012. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proceedings of the National Academy of Sciences of the United States of America, 109, E2579–E2586.Geurts A M, Cost G J, Freyvert Y, Zeitler B, Miller J C, Choi V M, Jenkins S S, Wood A, Cui X, Meng X. 2009. Knockout rats via embryo microinjection of zinc-finger nucleases. Science, 325, 433–433.Goldberg E B, Bensadoun A, Brown W J. 2007. Characterization of PNPLA5/GS2-like neutral lipase and identification its lipid droplet targeting motif. Faseb Journal, 21, A236–A236.Gori J L, Hsu P D, Maeder M L, Shen S, Welstead G G, Bumcrot D. 2015. Delivery and specificity of CRISPR/Cas9 genome editing technologies for human gene therapy. Human Gene Therapy, 26, 443–451.Guilinger J P, Thompson D B, Liu D R. 2014. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nature Biotechnology, 32, 577–582.Hamra F K. 2010. Gene targeting: Enter the rat. Nature, 467, 161–163.Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna J A, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337, 816–821.Lake A C, Sun Y, Li J L, Kim J E, Johnson J W, Li D, Revett T, Shih H H, Liu W, Paulsen J E. 2005. Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members. Journal of Lipid Research, 46, 2477–2487.Lange L A, Hu Y, Zhang H, Xue C, Schmidt E M, Tang Z Z, Bizon C, Lange E M, Smith J D, Turner E H. 2014. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. The American Journal of Human Genetics, 94, 233–245.Lange L A, Willer C J, Rich S S. 2015. Recent developments in genome and exome-wide analyses of plasma lipids. Current Opinion in Lipidology, 26, 96–102.Li D, Qiu Z, Shao Y, Chen Y, Guan Y, Liu M, Li Y, Gao N, Wang L, Lu X. 2013. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nature Biotechnology, 31, 681–683.Li W, Teng F, Li T, Zhou Q. 2013. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nature Biotechnology, 31, 684–686.Ma Y, Ma J, Zhang X, Chen W, Yu L, Lu Y, Bai L, Shen B, Huang X, Zhang L. 2014a. Generation of eGFP and Cre knockin rats by CRISPR/Cas9. FEBS Journal, 281, 3779–3790.Ma Y, Shen B, Zhang X, Lu Y, Chen W, Ma J, Huang X, Zhang L. 2014b. Heritable multiplex genetic engineering in rats using CRISPR/Cas9. PLoS ONE, 9, e89413.Ma Y, Zhang X, Shen B, Lu Y, Chen W, Ma J, Bai L, Huang X, Zhang L. 2014c. Generating rats with conditional alleles using CRISPR/Cas9. Cell Research, 24, 122–125.Mali P, Aach J, Stranges P B, Esvelt K M, Moosburner M, Kosuri S, Yang L, Church G M. 2013a. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nature Biotechnology, 31, 833–838.Mali P, Yang L, Esvelt K M, Aach J, Guell M, DiCarlo J E, Norville J E, Church G M. 2013b. RNA-guided human genome engineering via Cas9. Science, 339, 823–826.Miller J C, Tan S, Qiao G, Barlow K A, Wang J, Xia D F, Meng X, Paschon D E, Leung E, Hinkley S J. 2011. A TALE nuclease architecture for efficient genome editing. Nature Biotechnology, 29, 143–148.Murugesan S, Goldberg E B, Brown W J. 2008. Conserved C-terminal arginines are crucial for targeting PNPLA5/GS2-like triglyceride lipase to lipid droplets. The FASEB Journal, 22, 643.11.Sapranauskas R, Gasiunas G, Fremaux C, Barrangou R, Horvath P, Siksnys V. 2011. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Research, 39, 9275–9282.Schmidt E M, Willer C J. 2015. Insights into blood lipids from rare variant discovery. Current Opinion in Genetics & Development, 33, 25–31.Shalem O, Sanjana N E, Hartenian E, Shi X, Scott D A, Mikkelsen T S, Heckl D, Ebert B L, Root D E, Doench J G. 2014. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science, 343, 84–87.Shen B, Zhang J, Wu H, Wang J, Ma K, Li Z, Zhang X, Zhang P, Huang X. 2013. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Research, 23, 720–723.Tesson L, Usal C, Ménoret S, Leung E, Niles B J, Remy S, Santiago Y, Vincent A I, Meng X, Zhang L. 2011. Knockout rats generated by embryo microinjection of TALENs. Nature Biotechnology, 29, 695–696.Tong C, Li P, Wu N L, Yan Y, Ying Q L. 2010. Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature, 467, 211–213.Tsai S Q, Wyvekens N, Khayter C, Foden J A, Thapar V, Reyon D, Goodwin M J, Aryee M J, Joung J K. 2014. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nature Biotechnology, 32, 569–576.Villena J A, Roy S, Sarkadi-Nagy E, Kim K H, Sul H S. 2004. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids ectopic expression of desnutrin increases triglyceride hydrolysis. Journal of Biological Chemistry, 279, 47066–47075.Wang H, Yang H, Shivalila C S, Dawlaty M M, Cheng A W, Zhang F, Jaenisch R. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 153, 910–918.Wang T, Wei J J, Sabatini D M, Lander E S. 2014. Genetic screens in human cells using the CRISPR-Cas9 system. Science, 343, 80–84.Wilson P A, Gardner S D, Lambie N M, Commans S A, Crowther D J. 2006. Characterization of the human patatin-like phospholipase family. Journal of Lipid Research, 47, 1940–1949.Yang H, Wang H, Shivalila C S, Cheng A W, Shi L, Jaenisch R. 2013. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell, 154, 1370–1379. |
